Daniel Brennan - Net Worth and Insider Trading

Daniel Brennan Net Worth

The estimated net worth of Daniel Brennan is at least $0 dollars as of 2024-11-13. Daniel Brennan is the Exec VP & Chf Operations Off. of Insys Therapeutics Inc and owns about 1 shares of Insys Therapeutics Inc (INSYQ) stock worth over $0. Details can be seen in Daniel Brennan's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Daniel Brennan has not made any transactions after 2016-08-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Daniel Brennan

To

Daniel Brennan Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Daniel Brennan owns 3 companies in total, including Catalyst Pharmaceuticals Inc (CPRX) , PDS Biotechnology Corp (PDSB) , and Insys Therapeutics Inc (INSYQ) .

Click here to see the complete history of Daniel Brennan’s form 4 insider trades.

Insider Ownership Summary of Daniel Brennan

Ticker Comapny Transaction Date Type of Owner
CPRX Catalyst Pharmaceuticals Inc 2018-06-13 Chief Commercial Officer
PDSB PDS Biotechnology Corp 2016-10-17 Chief Operating Officer
INSYQ Insys Therapeutics Inc 2016-08-09 Exec VP & Chf Operations Off.

Daniel Brennan Latest Holdings Summary

Daniel Brennan currently owns a total of 1 stock. Daniel Brennan owns 1 shares of Insys Therapeutics Inc (INSYQ) as of August 9, 2016, with a value of $0.

Latest Holdings of Daniel Brennan

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
INSYQ Insys Therapeutics Inc 2016-08-09 1 0.04 0

Holding Weightings of Daniel Brennan


Daniel Brennan Form 4 Trading Tracker

According to the SEC Form 4 filings, Daniel Brennan has made a total of 0 transactions in Insys Therapeutics Inc (INSYQ) over the past 5 years. The most-recent trade in Insys Therapeutics Inc is the sale of 5,781 shares on August 9, 2016, which brought Daniel Brennan around $110,764.

Insider Trading History of Daniel Brennan

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Daniel Brennan Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Daniel Brennan Ownership Network

Ownership Network List of Daniel Brennan

No Data

Ownership Network Relation of Daniel Brennan

Insider Network Chart

Daniel Brennan Owned Company Details

What does Catalyst Pharmaceuticals Inc do?

Who are the key executives at Catalyst Pharmaceuticals Inc?

Daniel Brennan is the Chief Commercial Officer of Catalyst Pharmaceuticals Inc. Other key executives at Catalyst Pharmaceuticals Inc include VP Development & Management Steve Miller , Chief Commercial Officer Carmen Jeffrey Del , and Chief Medical Officer Gary Ingenito .

Catalyst Pharmaceuticals Inc (CPRX) Insider Trades Summary

Over the past 18 months, Daniel Brennan made no insider transaction in Catalyst Pharmaceuticals Inc (CPRX). Other recent insider transactions involving Catalyst Pharmaceuticals Inc (CPRX) include a net sale of 230,000 shares made by Gary Ingenito , a net sale of 90,000 shares made by David S Tierney , and a net sale of 190,000 shares made by Steve Miller .

In summary, during the past 3 months, insiders sold 165,000 shares of Catalyst Pharmaceuticals Inc (CPRX) in total and bought 0 shares, with a net sale of 165,000 shares. During the past 18 months, 741,406 shares of Catalyst Pharmaceuticals Inc (CPRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 741,406 shares.

Catalyst Pharmaceuticals Inc (CPRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Catalyst Pharmaceuticals Inc Insider Transactions

No Available Data

Daniel Brennan Mailing Address

Above is the net worth, insider trading, and ownership report for Daniel Brennan. You might contact Daniel Brennan via mailing address: C/o Insys Therapeutics, Inc, 1333 South Spectrum Blvd, Suite 100, Chandler Az 85286.